New vaccine to reduce malaria deaths by 70% soon available

The medical journal The Lancet published the results of a second malaria vaccine on Thursday, a year after the World Health Organization (WHO) recommended a first vaccine.

According to figures published in The Lancet, the R21 Matrix-M vaccine developed by scientists at Oxford University is between 70% and 80% effective based on results observed after a booster dose of malaria vaccine.

The R21 Matrix-M vaccine has a double advantage: in addition to being more effective than the first, it could be easily produced in large quantities, in order to hope for a 70% decrease in malaria-related deaths by 2030.